Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A8202 Abiraterone acetateTarget: Cytochrome P450 (CYP450)Summary: Cytochrome p450 17a1 inhibitor
-
A4240 Abiraterone1 CitationSummary: Potent CYP17 inhibitor
-
A4308 AlizarinSummary: Chelator for calcium,used to stain calcium deposites,Alizarin complexone is used for bone staining to study bone remodeling
-
A4311 PF-4981517Summary: CYP3A4 inhibitor,potent and selective
-
A4316 KetoconazoleTarget: Cytochrome P450 (CYP450)Summary: Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase
-
A4318 AvasimibeTarget: Acyl coenzyme A: cholesterol acyltransferasesSummary: ACAT inhibitor,orally bioavailable
-
B1240 (+)-KetoconazoleSummary: Potent inhibitor of cytochrome P450c17
-
C3414 (S)-MephenytoinSummary: substrate of the cytochrome P450 (CYP) isoform CYP2C19
-
C3471 Omeprazole sulfoneSummary: CYP2C19 inhibitor
-
C3560 SKF 525A (hydrochloride)Summary: cytochrome P (CYP)450 inhibitor